PYC Therapeutics Ltd Sustainability Reports
PYC Therapeutics Limited is a clinical-stage biotechnology company developing a new generation of RNA therapies using a proprietary drug delivery platform. The company's pipeline mainly targets severe genetic diseases, such as inherited blinding eye conditions and kidney diseases, that have no alternative treatment options.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
FIGI: BBG001SJ8P65
2 reports from 2015 to 2023